Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 1 21Phase NA 15Phase 3 11Phase 1/2 10Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 2

Status

Completed 8Recruiting 5Unknown 3Active not recruiting 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 29Thoracic 21Breast 14Other hematologic neoplasm 13Genitourinary 11Lymphoid 10Gynecologic 9Head & Neck 8Dermatologic 6CNS 6Sarcoma 5Myeloid 5Plasma cell 4Tumor-Agnostic 3Other 2Endocrine 2Other solid neoplasm 1NET 1Classical hematology 1

Conditions

Vipoma 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Somatostatinoma 1Neuroendocrine Tumors 1Neoplasms 1Lung Neoplasms 1Insulinoma 1Glucagonoma 1Gastrinoma 1Carcinoma, Islet Cell 1Adenoma, Islet Cell 1

Interventions

fosbretabulin 1combretastatin 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Fluorouracil 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × Endocrine × Clear all
NCT00227617 2023-05-22

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

University of California, San Francisco

Phase 2/3 Terminated
36 enrolled 14 charts
EndocrineNETThoracic

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT00507429 2014-06-09

FACT

Mateon Therapeutics

Phase 2/3 Terminated
80 enrolled 10 charts
EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡